Advertisement
UK markets closed

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     

  • CRUDE OIL

    83.04
    +0.35 (+0.42%)
     

  • GOLD FUTURES

    2,401.10
    +12.70 (+0.53%)
     

  • DOW

    37,724.44
    -28.87 (-0.08%)
     

  • Bitcoin GBP

    50,917.39
    +2,114.72 (+4.33%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • NASDAQ Composite

    15,621.17
    -62.20 (-0.40%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Is Now a Good Time to Buy Ocugen?

Prosper Junior Bakiny, The Motley Fool
·4-min read
Is Now a Good Time to Buy Ocugen?

In the coronavirus vaccine market, several players -- including Moderna and Pfizer -- are currently benefiting from a first-mover advantage. One of them is Ocugen (NASDAQ: OCGN), a company that partnered with India-based Bharat Biotech to develop and market a COVID-19 vaccine called Covaxin. Like many other meme stocks, shares of Ocugen have been highly volatile since the beginning of the year -- and a recent regulatory breakthrough in India sent the company's stock soaring through the roof.

Continue reading